Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer
- First Posted Date
- 2014-02-12
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT02060669
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome
Completed
- Conditions
- Myelodysplastic Syndrome
- Interventions
- Genetic: spliceosome
- First Posted Date
- 2014-02-12
- Last Posted Date
- 2014-02-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 58
- Registration Number
- NCT02060409
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Platelet Response During the Second Cycle of Decitabine Can Predict Response and Survival for Myelodysplastic Syndrome
- Conditions
- Myelodysplastic Syndrome
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2014-01-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1
- Registration Number
- NCT02045654
- Locations
- π°π·
Division of Hematology Oncology, Samsung Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia
Phase 4
Completed
- Conditions
- Neurogenic Lower Urinary Tract Dysfunction
- Interventions
- Drug: NaftofidilDrug: Tamsulosin
- First Posted Date
- 2014-01-13
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 194
- Registration Number
- NCT02034604
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Comparison Between Invasive Pressure Flow Study and Non-invasive Penile Cuff Test
Completed
- Conditions
- Bladder Outlet ObstructionPressure Flow Study
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 335
- Registration Number
- NCT02031653
- Locations
- π°π·
Samsung Medical Center, Seoul,, Korea, Republic of
Biomarker Analysis in Metastatic Colorectal Cancer Treated With Cetuximab
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT02029326
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients
- First Posted Date
- 2014-01-03
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 43
- Registration Number
- NCT02026583
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis
Phase 2
Completed
- Conditions
- HER2-positive Gastric Cancer Patients With Liver Metastasis
- Interventions
- First Posted Date
- 2013-12-19
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT02015169
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Korea, Republic of
Naftopidil 75mg for Improving Clearance of Urinary Stones
- First Posted Date
- 2013-12-13
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 130
- Registration Number
- NCT02011737
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Perioperative Changes of Heart Rate Variability Related to Anxiety and Depressiveness in Patients Undergoing General Anesthesia
Completed
- Conditions
- SDSGeneral AnesthesiaHeart Rate VariabilitySTAIAnxiety
- First Posted Date
- 2013-12-13
- Last Posted Date
- 2014-11-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT02011074
- Locations
- π°π·
Kim Myunghee, Gangnamgu, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath